NO20015396L - Anvendelse av löselige kostimulerende molekyler for å forsterke immunresponser - Google Patents

Anvendelse av löselige kostimulerende molekyler for å forsterke immunresponser

Info

Publication number
NO20015396L
NO20015396L NO20015396A NO20015396A NO20015396L NO 20015396 L NO20015396 L NO 20015396L NO 20015396 A NO20015396 A NO 20015396A NO 20015396 A NO20015396 A NO 20015396A NO 20015396 L NO20015396 L NO 20015396L
Authority
NO
Norway
Prior art keywords
immune responses
costimulatory molecules
enhance immune
soluble costimulatory
soluble
Prior art date
Application number
NO20015396A
Other languages
English (en)
Other versions
NO20015396D0 (no
Inventor
Knut Sturmhoefel
Stanley F Wolf
Margot O'toole
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst filed Critical Genetics Inst
Publication of NO20015396D0 publication Critical patent/NO20015396D0/no
Publication of NO20015396L publication Critical patent/NO20015396L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
NO20015396A 1999-05-06 2001-11-05 Anvendelse av löselige kostimulerende molekyler for å forsterke immunresponser NO20015396L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13294499P 1999-05-06 1999-05-06
PCT/US2000/012435 WO2000067788A2 (en) 1999-05-06 2000-05-05 Use of soluble costimulatory molecules to enhance immune responses

Publications (2)

Publication Number Publication Date
NO20015396D0 NO20015396D0 (no) 2001-11-05
NO20015396L true NO20015396L (no) 2002-01-02

Family

ID=22456295

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015396A NO20015396L (no) 1999-05-06 2001-11-05 Anvendelse av löselige kostimulerende molekyler for å forsterke immunresponser

Country Status (15)

Country Link
EP (1) EP1181053A2 (no)
JP (1) JP2002544170A (no)
KR (1) KR20020001865A (no)
CN (1) CN1377279A (no)
AU (1) AU4825700A (no)
BR (1) BR0010711A (no)
CA (1) CA2373256A1 (no)
CZ (1) CZ20013964A3 (no)
HK (1) HK1041810A1 (no)
HU (1) HUP0201222A3 (no)
IL (1) IL146106A0 (no)
NO (1) NO20015396L (no)
PL (1) PL360915A1 (no)
WO (1) WO2000067788A2 (no)
ZA (1) ZA200109376B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112655B1 (en) 1997-02-27 2006-09-26 Japan Tobacco, Inc. JTT-1 protein and methods of inhibiting lymphocyte activation
JP3521382B2 (ja) 1997-02-27 2004-04-19 日本たばこ産業株式会社 細胞間接着及びシグナル伝達を媒介する細胞表面分子
JP3871503B2 (ja) 1999-08-30 2007-01-24 日本たばこ産業株式会社 免疫性疾患治療剤
JP4210454B2 (ja) 2001-03-27 2009-01-21 日本たばこ産業株式会社 炎症性腸疾患治療剤
JP3597140B2 (ja) 2000-05-18 2004-12-02 日本たばこ産業株式会社 副刺激伝達分子ａｉｌｉｍに対するヒトモノクローナル抗体及びその医薬用途
JP4212278B2 (ja) 2001-03-01 2009-01-21 日本たばこ産業株式会社 移植片拒絶反応抑制剤
AU2006265986B2 (en) * 2005-06-30 2012-02-23 Eisai R&D Management Co., Ltd Compounds for preparing immunological adjuvant
MX2008007287A (es) 2005-12-08 2008-10-27 Univ Louisville Res Found Metodos y composiciones para expandir celulas reguladoras t.
MX2008007292A (es) 2005-12-08 2008-10-17 Univ Louisville Res Found Composiciones inmunoestimuladoras y metodos.
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
CA2843274A1 (en) 2011-07-29 2013-02-07 Selecta Biosciences, Inc. Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
WO2013151731A1 (en) * 2012-04-02 2013-10-10 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium for induction of cellular immune response
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
US10124045B2 (en) 2013-11-04 2018-11-13 Uti Limited Partnership Methods and compositions for sustained immunotherapy
WO2016198932A2 (en) 2015-05-06 2016-12-15 Uti Limited Partnership Nanoparticle compositions for sustained therapy
CN110743006B (zh) * 2019-11-22 2020-08-25 北京启辰生生物科技有限公司 用于协同解除免疫细胞衰竭的组合物及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE251181T1 (de) * 1998-07-28 2003-10-15 Micromet Ag Heterominikörper

Also Published As

Publication number Publication date
HK1041810A1 (zh) 2002-07-26
ZA200109376B (en) 2003-03-13
AU4825700A (en) 2000-11-21
NO20015396D0 (no) 2001-11-05
EP1181053A2 (en) 2002-02-27
CZ20013964A3 (cs) 2002-06-12
WO2000067788A2 (en) 2000-11-16
WO2000067788A3 (en) 2001-04-05
CN1377279A (zh) 2002-10-30
BR0010711A (pt) 2002-02-13
IL146106A0 (en) 2002-07-25
JP2002544170A (ja) 2002-12-24
HUP0201222A3 (en) 2004-07-28
HUP0201222A2 (en) 2002-08-28
PL360915A1 (en) 2004-09-20
CA2373256A1 (en) 2000-11-16
KR20020001865A (ko) 2002-01-09

Similar Documents

Publication Publication Date Title
NO20015396D0 (no) Anvendelse av löselige kostimulerende molekyler for å forsterke immunresponser
NO20004133D0 (no) Antistoffer mot human CD40
NO20020799D0 (no) Anordning for å ekstrahere en substans for tilberedning av en drikke
NO20012312L (no) Infraröd avbildning for å påvise komponenter på hygienie artikler
HK1061403A1 (en) ANTIBODIES TO HUMAN IL-1ß
DE60036968D1 (de) Adamantanderivate zur Behandlung von entzündlichen, immunologischen und kardiovaskulären Erkrankungen
HUP0301477A3 (en) Antibodies to human mcp-1 molecule
NO20020779D0 (no) Fremgangsmåter, preparater og sett for å fremme helbredelse ved skader på sentralnervesystemet
NO995617L (no) Anvendelse av en CD40:CD154 bindingsforstyrrer for å forhindre mot-adaptive immunresponser, spesielt transplantatavstoetning
EE04747B1 (et) Amiini-plaatina komplekside valmistamismeetod
NO20015227D0 (no) Fremgangsmåte for å öke effektiviteten til anti-cancer midler
AU6949800A (en) Compositions and methods for the treatment of sepsis using antibodies to c5a
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20021159D0 (no) Fremgangsmåte for interferometrisk prosessering for å identifisere lag-grenser
NO20003358D0 (no) Koblingsinnretning til innbyrdes forbindelse av to gjenstander
ID30308A (id) Aparatus elektronik mudah dibawa
AU2086501A (en) Inducing cellular immune responses to carcinoembryonic antigen using peptide andnucleic acid compositions
IS6381A (is) Nýjung við notkun mótefna í bóluefni
NO20010842D0 (no) Forbindelseselement for sammenkobling av to komponenter
ATE241622T1 (de) Thiazolidindion-derivate als antidiabetika
ID28435A (id) Handuk pembersih dapur dan metode untuk memproduksinya
AU2002249917A1 (en) Induction of immune responses to isoaspartyl-modified antigens
NO20021574D0 (no) Fremgangsmåte for å forbedre opplöseligheten av trisykliske aminoalkoholderivater
AU5801398A (en) The use of cd4-binding small molecules to inhibit immune responses
NO20011412D0 (no) FremgangsmÕter for nedmodulering av immunresponsen til terapeutiske proteiner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application